Aclaris Therapeutics, Inc. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aclaris Therapeutics, Inc. for December 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 2,925 | 0 | 5,850 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 21,233 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.12 | 889 | 21,443 | 878,166 | 879.1 K to 878.2 K (-0.10 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 2,925 | 0 | 879,055 | 876.1 K to 879.1 K (+0.33 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.23 | 922 | 22,340 | 876,130 | 877.1 K to 876.1 K (-0.11 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 877,052 | 874 K to 877.1 K (+0.35 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.12 | 380 | 9,166 | 145,347 | 145.7 K to 145.3 K (-0.26 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,250 | 0 | 145,727 | 144.5 K to 145.7 K (+0.87 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 144,477 | 144.9 K to 144.5 K (-0.27 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 144,872 | 143.6 K to 144.9 K (+0.91 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,625 | 0 | 3,250 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Payment of Exercise | F | 24.12 | 494 | 11,915 | 133,601 | 134.1 K to 133.6 K (-0.37 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Buy | M | 0.00 | 1,625 | 0 | 134,095 | 132.5 K to 134.1 K (+1.23 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 132,470 | 132.9 K to 132.5 K (-0.30 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Buy | M | 0.00 | 1,300 | 0 | 132,865 | 131.6 K to 132.9 K (+0.99 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 2,150 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 12,133 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.12 | 327 | 7,887 | 78,659 | 79 K to 78.7 K (-0.41 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 78,986 | 77.9 K to 79 K (+1.38 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.23 | 527 | 12,769 | 77,911 | 78.4 K to 77.9 K (-0.67 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 78,438 | 76.7 K to 78.4 K (+2.26 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,450 | 0 | 2,900 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 24.12 | 441 | 10,637 | 263,792 | 264.2 K to 263.8 K (-0.17 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,450 | 0 | 264,233 | 262.8 K to 264.2 K (+0.55 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 262,783 | 263.2 K to 262.8 K (-0.15 %) |
| Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 263,178 | 261.9 K to 263.2 K (+0.50 %) |